Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

This article, published in the Journal of Infectious Diseases, investigates the impact of meningococcal serogroup C conjugate vaccine introduction in the United Kingdom on asymptomatic carriage of meningococci to establish whether serogroup replacement or protection by herd immunity occurred. The study found that the impact of vaccination with meningococcal serogroup C conjugate vaccine on the prevalence of carriage of group C meningococci was consistent with herd immunity.

Author(s): Maiden MCJ, Ibarz-Pavón AB, Urwin R, et al.

Published: 2008

  • Visit web page (English)

    (Located at www.journals.uchicago.edu)

    Citation: Maiden MCJ, Ibarz-Pavón AB, Urwin R, et al. Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. Journal of Infectious Diseases. 2008;197(5):737-743.